Risk of central nervous system metastasis and survival in HER2+ positive breast and non-breast cancers
{{output}}
Background: Incidence, survival, and optimal choice of therapy for central nervous system (CNS) metastasis are well characterized in human epidermal growth factor receptor 2 positive (HER2+) breast cancer (BC), yet remain poorly ... ...